{"source_content":"请务必阅读正文之后的免责条款部分守正出奇宁静致远[Table_Title]医疗保健制药、生物科技与生命科学20Q3单季度收入利润高增长，医美龙头后疫情期成长动力渐显[Table_Summary]事件：公司发布2020年三季报，实现收入4.64亿元，同比+17.4%，归母净利润2.94亿元，同比+31.83%，Q3单季度实现收入2.23亿（+43.18%），归母净利润1.43亿（+55.97%）。单季度收入与利润端增速环比提升明显，主要系后疫情时期医美需求恢复较快所致。盈利能力相对稳定，居高不下。Q3单季度毛利率92.97%，较同期略降0.32pct，维持在92%以上的较高水平。Q3单季度净利率63.73%，较同期提升6.15pct。主要系费用率下降较多，规模效应提升所致。费用率有所下降，营运效率提升。20Q1-Q3销售费用率9.05%，较同期下降2.61pct；管理费用率5.74%，较同期下降3.25pct；研发费用率7.12%，较同期下降0.69pct；财务费用率-0.27%，较同期基本持平。费用端体现营运效率提升，规模效应体现，预计全年仍将维持此趋势。20Q1-Q3经营性现金流2.59亿元（+20.5%），现金流稳定质量较高，周转能力良好。优质行业、优质赛道中的优质公司。我国医疗美容市场是全球增速最快的医美市场之一：经济的发展、人均可支配收入的增加、购买力和低渗透率基数为未来提供了增长空间。而在整个大医美行业中，非手术类微整形仍处于高速发展和扩张期，相比于手术类整形，以注射类为代表的非手术类微创医疗美容，恢复时间快、价格及风险相对较低，因此有更高的市场接受度和复购率，是最好的赛道之一。爱美客深耕透明质酸以及医用软组织修复材料多年，未来有望享受研发实力带来的高竞争壁垒+行业增长红利+产品迭代更新需求。核心独家产品嗨体提供高增长动力，宝尼达等产品也拥有较高的行业地位，且公司在研产品丰富，童颜针，肉毒素等均走在市场前沿，未来公司产品矩阵有望进一步丰富，提升成长天花板。投资建议：预计公司2020-2022年净利润3.97/6.11/8.56亿元，对应2020/2021/2022年PE分别为148/96/69倍，对标行业估值，考虑到新股溢价和公司的扩张空间与高增速，给予买入评级，长期看好。风险提示：疫情反复影响消费，新产品研发不达预期。[Table_ProfitInfo]盈利预测和财务指标：20192020E2021E2022E营业收入(百万元)557.7719.91,128.01,568.0（+/-%）73.7%29.1%56.7%39.0%净利润(百万元）305.52397.42611.16856.38（+/-%）148.7%30.1%53.8%40.1%摊薄每股收益(元)2.5423.3065.0847.125市盈率(PE)163.26148.2396.3968.79走势比较[Table_Info]股票数据总股本/流通(百万股)120/26总市值/流通(百万元)49,883/10,79312个月最高/最低(元)454.00/330.24[Table_ReportInfo]相关研究报告：[Table_Author]证券分析师：郭彬电话：18621965840E-MAIL：guobin@tpyzq.com执业资格证书编码：S119051909001(10%)(1%)7%16%25%33%19/10/2819/12/2820/2/2820/4/2820/6/2820/8/28爱美客沪深300[Table_Message]2020-10-27公司点评报告买入/首次爱美客(300896)目标价：612.6昨收盘：415.0公司研究报告太平洋证券股份有限公司证券研究报告公司点评报告P2报告标题请务必阅读正文之后的免责条款部分守正出奇宁静致远资料来源：Wind，太平洋证券注：摊薄每股收益按最新总股本计算公司点评报告P3报告标题请务必阅读正文之后的免责条款部分守正出奇宁静致远[TABLE_FINANCEINFO]资产负债表(百万）利润表(百万）2018A2019A2020E2021E2022E2018A2019A2020E2021E2022E货币资金2665067411,1991,896营业收入321557.7719.91,128.01,568.0应收和预付款项1117223448营业成本34416599143存货1323375681营业税金及附加645710其他流动资产719212530销售费用627786141199流动资产合计2965658211,3152,055管理费用444865107135长期股权投资00000财务费用-2-2-5-7-11投资性房地产180000资产减值损失10000固定资产138151313469628投资收益17132028在建工程公允价值变动00000无形资产开发支出911111111营业利润143350456701983长期待摊费用其他非经营损益01000其他非流动资产1918181818利润总额143351456701983资产总计4647441,1621,8122,711所得税275368105147短期借款00000净利润116298388596835应付和预收款项2318284463少数股东损益-7-8-10-15-21长期借款00000归母股东净利润123305.52397.42611.16856.38其他负债00000负债合计1414141414预测指标股本90909090902018A2019A2020E2021E2022E资本公积140140140140140毛利率89.3%92.6%91.0%91.2%90.9%留存收益00000销售净利率38.3%54.8%55.2%54.2%54.6%归母公司股东权益3986591,0561,6682,524销售收入增长率44.3%73.7%29.1%56.7%39.0%少数股东权益64-6-21-42EBIT增长率43.6%60.8%60.4%59.3%59.7%股东权益合计4056631,0501,6462,482净利润增长率49.5%148.7%30.1%53.8%40.1%负债和股东权益4647441,1621,8122,711ROE30.8%46.4%37.6%36.7%33.9%ROA26.5%41.1%34.2%33.7%31.6%现金流量表(百万）ROIC28.1%43.5%35.2%34.5%32.0%2018A2019A2020E2021E2022EEPS(X)1.0222.5423.3065.0847.125经营性现金流135310395611842PE(X)479.53192.79148.2396.3968.79投资性现金流-38-26-160-153-145PB(X)147.8589.3955.7735.3323.34融资性现金流-46-44000PS(X)183.48105.6181.8252.2237.56现金增加额51240235458697EV/EBITDA(X)-1.4597.2162.6044.44-1.45资料来源：WIND，太平洋证券公司点评报告P2报告标题请务必阅读正文之后的免责条款部分守正出奇宁静致远投资评级说明1、行业评级看好：我们预计未来6个月内，行业整体回报高于市场整体水平5%以上；中性：我们预计未来6个月内，行业整体回报介于市场整体水平－5%与5%之间；看淡：我们预计未来6个月内，行业整体回报低于市场整体水平5%以下。2、公司评级买入：我们预计未来6个月内，个股相对大盘涨幅在15%以上；增持：我们预计未来6个月内，个股相对大盘涨幅介于5%与15%之间；持有：我们预计未来6个月内，个股相对大盘涨幅介于-5%与5%之间；减持：我们预计未来6个月内，个股相对大盘涨幅介于-5%与-15%之间；销售团队[Table_Team]职务姓名手机邮箱全国销售总监王均丽13910596682wangjl@tpyzq.com华北销售副总监成小勇18519233712chengxy@tpyzq.com华北销售孟超13581759033mengchao@tpyzq.com华北销售韦珂嘉13701050353weikj@tpyzq.com华北销售韦洪涛13269328776weiht@tpyzq.com华东销售总监陈辉弥13564966111chenhm@tpyzq.com华东销售副总监梁金萍15999569845liangjp@tpyzq.com华东销售杨海萍17717461796yanghp@tpyzq.com华东销售杨晶18616086730yangjinga@tpyzq.com华东销售秦娟娟18717767929qinjj@tpyzq.com华东销售王玉琪17321189545wangyq@tpyzq.com华东销售慈晓聪18621268712cixc@tpyzq.com华东销售郭瑜18758280661guoyu@tpyzq.com华东销售徐丽闵17305260759xulm@tpyzq.com华南销售总监张茜萍13923766888zhangqp@tpyzq.com华南销售副总监查方龙18565481133zhafl@tpyzq.com华南销售张卓粤13554982912zhangzy@tpyzq.com华南销售张靖雯18589058561zhangjingwen@tpyzq.com华南销售何艺雯13527560506heyw@tpyzq.com研究院中国北京100044北京市西城区北展北街九号华远·企业号D座电话：(8610)88321761传真：(8610)88321566重要声明太平洋证券股份有限公司具有证券投资咨询业务资格，经营证券业务许可证编号13480000。本报告信息均来源于公开资料，我公司对这些信息的准确性和完整性不作任何保证。负责准备本报告以及撰写本报告的所有研究分析师或工作人员在此保证，本研究报告中关于任何发行商或证券所发表的观点均如实反映分析人员的个人观点。报告中的内容和意见仅供参考，并不构成对所述证券买卖的出价或询价。我公司及其雇员对使用本报告及其内容所引发的任何直接或间接损失概不负责。我公司或关联机构可能会持有报告中所提到的公司所发行的证券头寸并进行交易，还可能为这些公司提供或争取提供投资银行业务服务。本报告版权归太平洋证券股份有限公司所有，未经书面许可任何机构和个人不得以任何形式翻版、复制、刊登。任何人使用本报告，视为同意以上声明。","data":[{"id":"1","source_document":"爱美客（300896）：20Q3单季度收入利润高增长，医美龙头后疫情期成长动力渐显.pdf","content":"公司发布2020年三季报，实现收入4.64亿元，同比+17.4%","content_offset":["100","132"],"indicators":[{"indicator_name":"收入","indicator_value":["4.64亿元","117","123"],"indicator_element":{"时间":["2020年三季","104","111"],"公司":["爱美客","706","709"]},"indicator_supplement":{"属性":""}}]},{"id":"2","source_document":"爱美客（300896）：20Q3单季度收入利润高增长，医美龙头后疫情期成长动力渐显.pdf","content":"公司发布2020年三季报，实现收入4.64亿元，同比+17.4%","content_offset":["100","132"],"indicators":[{"indicator_name":"收入同比","indicator_value":["17.4%","127","132"],"indicator_element":{"时间":["2020年三季","104","111"],"公司":["爱美客","706","709"]},"indicator_supplement":{"属性":""}}]},{"id":"3","source_document":"爱美客（300896）：20Q3单季度收入利润高增长，医美龙头后疫情期成长动力渐显.pdf","content":"归母净利润2.94亿元，同比+31.83%","content_offset":["133","154"],"indicators":[{"indicator_name":"归母净利润","indicator_value":["2.94亿元","138","144"],"indicator_element":{"时间":["2020年三季","104","111"],"公司":["爱美客","706","709"]},"indicator_supplement":{"属性":""}}]},{"id":"4","source_document":"爱美客（300896）：20Q3单季度收入利润高增长，医美龙头后疫情期成长动力渐显.pdf","content":"归母净利润2.94亿元，同比+31.83%","content_offset":["133","154"],"indicators":[{"indicator_name":"归母净利润同比","indicator_value":["31.83%","148","154"],"indicator_element":{"时间":["2020年三季","104","111"],"公司":["爱美客","706","709"]},"indicator_supplement":{"属性":""}}]},{"id":"5","source_document":"爱美客（300896）：20Q3单季度收入利润高增长，医美龙头后疫情期成长动力渐显.pdf","content":"Q3单季度实现收入2.23亿（+43.18%）","content_offset":["155","178"],"indicators":[{"indicator_name":"收入","indicator_value":["2.23亿","164","169"],"indicator_element":{"时间":["Q3","155","157"],"公司":["爱美客","706","709"]},"indicator_supplement":{"属性":""}}]},{"id":"6","source_document":"爱美客（300896）：20Q3单季度收入利润高增长，医美龙头后疫情期成长动力渐显.pdf","content":"Q3单季度实现收入2.23亿（+43.18%）","content_offset":["155","178"],"indicators":[{"indicator_name":"收入同比","indicator_value":["43.18%","171","177"],"indicator_element":{"时间":["Q3","155","157"],"公司":["爱美客","706","709"]},"indicator_supplement":{"属性":""}}]},{"id":"7","source_document":"爱美客（300896）：20Q3单季度收入利润高增长，医美龙头后疫情期成长动力渐显.pdf","content":"归母净利润1.43亿（+55.97%）","content_offset":["179","198"],"indicators":[{"indicator_name":"归母净利润","indicator_value":["1.43亿元","-1","-1"],"indicator_element":{"时间":["Q3","155","157"],"公司":["爱美客","706","709"]},"indicator_supplement":{"属性":""}}]},{"id":"8","source_document":"爱美客（300896）：20Q3单季度收入利润高增长，医美龙头后疫情期成长动力渐显.pdf","content":"归母净利润1.43亿（+55.97%）","content_offset":["179","198"],"indicators":[{"indicator_name":"归母净利润同比","indicator_value":["55.97%","191","197"],"indicator_element":{"时间":["Q3","155","157"],"公司":["爱美客","706","709"]},"indicator_supplement":{"属性":""}}]},{"id":"9","source_document":"爱美客（300896）：20Q3单季度收入利润高增长，医美龙头后疫情期成长动力渐显.pdf","content":"Q3单季度毛利率92.97%，较同期略降0.32pct，维持在92%以上的较高水平","content_offset":["250","291"],"indicators":[{"indicator_name":"毛利率","indicator_value":["92.97%","258","264"],"indicator_element":{"时间":["Q3","250","252"],"公司":["爱美客","706","709"]},"indicator_supplement":{"属性":""}}]},{"id":"10","source_document":"爱美客（300896）：20Q3单季度收入利润高增长，医美龙头后疫情期成长动力渐显.pdf","content":"Q3单季度净利率63.73%，较同期提升6.15pct","content_offset":["292","319"],"indicators":[{"indicator_name":"净利率","indicator_value":["63.73%","300","306"],"indicator_element":{"时间":["Q3","292","294"],"公司":["爱美客","706","709"]},"indicator_supplement":{"属性":""}}]},{"id":"11","source_document":"爱美客（300896）：20Q3单季度收入利润高增长，医美龙头后疫情期成长动力渐显.pdf","content":"20Q1-Q3销售费用率9.05%，较同期下降2.61pct；","content_offset":["355","386"],"indicators":[{"indicator_name":"销售费用率","indicator_value":["9.05%","367","372"],"indicator_element":{"时间":["20Q1-Q3","355","362"],"公司":["爱美客","706","709"]},"indicator_supplement":{"属性":""}}]},{"id":"12","source_document":"爱美客（300896）：20Q3单季度收入利润高增长，医美龙头后疫情期成长动力渐显.pdf","content":"管理费用率5.74%，较同期下降3.25pct","content_offset":["386","409"],"indicators":[{"indicator_name":"管理费用率","indicator_value":["5.74%","391","396"],"indicator_element":{"时间":["20Q1-Q3","355","362"],"公司":["爱美客","706","709"]},"indicator_supplement":{"属性":""}}]},{"id":"13","source_document":"爱美客（300896）：20Q3单季度收入利润高增长，医美龙头后疫情期成长动力渐显.pdf","content":"研发费用率7.12%，较同期下降0.69pct","content_offset":["410","433"],"indicators":[{"indicator_name":"研发费用率","indicator_value":["7.12%","415","420"],"indicator_element":{"时间":["20Q1-Q3","355","362"],"公司":["爱美客","706","709"]},"indicator_supplement":{"属性":""}}]},{"id":"14","source_document":"爱美客（300896）：20Q3单季度收入利润高增长，医美龙头后疫情期成长动力渐显.pdf","content":"20Q1-Q3经营性现金流2.59亿元（+20.5%）","content_offset":["485","512"],"indicators":[{"indicator_name":"经营性现金流","indicator_value":["2.59亿元","498","504"],"indicator_element":{"时间":["20Q1-Q3","485","492"],"公司":["爱美客","706","709"]},"indicator_supplement":{"属性":""}}]},{"id":"15","source_document":"爱美客（300896）：20Q3单季度收入利润高增长，医美龙头后疫情期成长动力渐显.pdf","content":"20Q1-Q3经营性现金流2.59亿元（+20.5%）","content_offset":["485","512"],"indicators":[{"indicator_name":"经营性现金流同比","indicator_value":["20.5%","506","511"],"indicator_element":{"时间":["20Q1-Q3","485","492"],"公司":["爱美客","706","709"]},"indicator_supplement":{"属性":""}}]},{"id":"16","source_document":"爱美客（300896）：20Q3单季度收入利润高增长，医美龙头后疫情期成长动力渐显.pdf","content":"预计公司2020-2022年净利润3.97/6.11/8.56亿元","content_offset":["852","885"],"indicators":[{"indicator_name":"净利润","indicator_value":["3.97亿元","-1","-1"],"indicator_element":{"时间":["2020-2022年","856","866"],"公司":["爱美客","1464","1467"]},"indicator_supplement":{"属性":"预计"}},{"indicator_name":"净利润","indicator_value":["6.11亿元","-1","-1"],"indicator_element":{"时间":["2020-2022年","856","866"],"公司":["爱美客","1464","1467"]},"indicator_supplement":{"属性":"预计"}},{"indicator_name":"净利润","indicator_value":["8.56亿元","879","885"],"indicator_element":{"时间":["2020-2022年","856","866"],"公司":["爱美客","1464","1467"]},"indicator_supplement":{"属性":"预计"}}]},{"id":"17","source_document":"爱美客（300896）：20Q3单季度收入利润高增长，医美龙头后疫情期成长动力渐显.pdf","content":"对应2020/2021/2022年PE分别为148/96/69倍","content_offset":["886","918"],"indicators":[{"indicator_name":"PE估值","indicator_value":["148倍","-1","-1"],"indicator_element":{"时间":["2020","888","892"],"公司":["爱美客","1464","1467"]},"indicator_supplement":{"属性":"预计"}},{"indicator_name":"PE估值","indicator_value":["96倍","-1","-1"],"indicator_element":{"时间":["2021","893","897"],"公司":["爱美客","1464","1467"]},"indicator_supplement":{"属性":"预计"}},{"indicator_name":"PE估值","indicator_value":["69倍","915","918"],"indicator_element":{"时间":["2022年","898","903"],"公司":["爱美客","1464","1467"]},"indicator_supplement":{"属性":"预计"}}]}]}